To compare radionuclide end-diastolic (EDV) and end-systolic (ESV) volumes with angiographic volume, we studied 52 patients with equilibrium radionuclide angiography using "mTc-human serum albumin within 48 hours of contrast angiography. Each RR interval was divided into 20-28 equally timed frames and a time-activity curve generated. End-diastolic counts were taken at the early peak of the curve and end-systolic counts at its nadir. Counts were divided by the total number of processed heart beats and normalized for: 1) dose per body surface area; 2) plasma volume; and 3) counts/ml of plasma. A cardiac phantom was developed and serial volumes were studied using a normalization factor. Radionuclide values were expressed as dimensionless units and compared with either biplane angiographic volumes (in the patient studies) or known phantom volumes. Good correlations were obtained with methods l and 2 in 35 patients (r > 0.84), but the best correlation was obtained in 17 patients when normalization for counts/ml of plasma was used (r = 0.98; y = 0.255 x -0.121). The standard error of the estimate (SEE) was ± 11.5 ml for EDV and ± 7.3 ml for ESV. The phantom study also showed an excellent correlation (r = 0.99), with a SEE of ± 6.5 ml. We conclude that a radionuclide method independent of geometric assumptions can be used to estimate left ventricular volume in man.
A NONTRAUMATIC METHOD of estimating left ventricular (LV) volume independent of geometric assumptions would be very desirable. In previous studies, the calculation of LV volume has required geometric models1-4 that may not be applicable, especially in the presence of asynergy. Because conventional contrast ventriculography, echocardiography and radionuclide angiography,5 12 with rare exceptions,13 all make use of such a priori assumptions, we attempted to develop an accurate method of estimating LV volume using equilibrium angiography, based on the count rate changes within the left ventricle.
Methods Theory and Equations
The hypothesis that LV volume can be calculated independent of geometry is based on the known characteristics of conventional radionuclide materials. Thus, radioactive materials used in equilibrium studies are distributed in such a manner that there is a stable concentration of isotopic activity for brief periods. If C = D/V (where C = concentration, D = administered dose and V = volume of distribution) and C is a constant or can be determined, then V may be calculated. Similarly, the volume of a particular region of interest (ROI) should be proportional to the amount of radiotracer in that ROI. Using computerderived time-activity curves, we developed four equa-tions and compared the volumes derived with contrast ventriculographic or phantom volumes in order to determine the most suitable. V = EDC or ESC X 0.04 second heart beats actual time/frame V _ EDC or ESC 0.04 heart beats time/frame 10 mCi/M2 BSA dose/M2 BSA (1) (2)
where EDC = end-diastolic counts, ESC = endsystolic counts, and BSA = body surface area.
In both equations 1 and 2, we assumed that the concentration of administered radioactive material remained constant. Because more radiopharmaceutical would produce greater activity, we attempted a dose normalization. Equation (2) differs from equation (1) in that the dose was normalized for BSA. All studies were normalized to a frame duration of 0.04 second, which we chose because it was the most convenient value for achieving up to 28 points in each composite time-activity (volume) curve when the heart rate was 54-71 beats/min. For faster heart rates, we selected shorter times for each frame, thus producing respectively shorter sampling and acquisition times. For heart rates of 72-107 beats/min, the time/frame was 0.03 second; for heart rates of 108-214 beats/min it was 0.02 second; and above 215 beats/min, it was 0.01 second. Since a 0.04 second/frame was the most commonly used in our rest population, it served as the "'standard" and normalization to this convenient time was made when briefer time frames were found.
Because longer studies produced higher total counts, all equations used counts per unit heart beat. Patients with atrial fibrillation or frequent atrial or ventricular premature depolarizations (more than four ectopic beats/min on the rhythm strip) were excluded. V (4), which was designed to deal with the following potential problems: I) the decay rate of the radioactive tracer over time, 2) the potential extravasation of the material during injection, and 3) a change in plasma volume over time. Equations (3) and (4) also consider pathologically or iatrogenically induced expansion or contraction of plasma volume.
Data Acquisition and Analysis

Human Studies
All patients were studied after intravenous injection and mixing of 99mTc-HSA (see Patients and Protocols for actual dosages). All studies were performed on supine patients by means of a single-crystal mobile scintillation camera detector in the 450 left anterior oblique (LAO) position, which included a 5-10°caudal tilt for maximal isolation of the left ventricle from the left atrium and right ventricle. A general purpose, low-energy, parallel-hole collimator was used. Data were stored on video magnetic tape as digital pulses and transferred to a minicomputer in real-time. Computations were performed using a commercially available nuclear medicine general purpose computer system (Medical Data Systems PAD). This system divides the RR interval into 20-28 equal time periods (frames), depending on the heart rate, and sums cardiac cycles at each corresponding frame to assemble a composite cardiac cycle. Each image frame has a spatial resolution of 64 X 64 channel elements (pixels).
Each LV time-activity curve was generated using a technique developed by the commercial manufacturer of the system. A special feature of the technique allows frame-by-frame adjustment of the LV ROI to closely approximate the outline of the chamber as it changes throughout the cardiac cycle. The ventricular border is computer-determined using a commercial algorithm that recognizes the "edge" by the point at which the second derivative of each of the multiple count-based, cross-sectional profiles of the chamber crosses the zero line. The operator assists in selecting the final ROI by placing a rectangular "window" around the ventricle as perceived on the image display and by choosing a count threshold level in order to make minor correction or alterations in the final ROI as necessary to conform to the actual image data. Nevertheless, ROI assignment is virtually automated to minimize interoperator variability. The background is chosen 2 pixels away from the end-diastolic edge on the end-diastolic frame. A computer-assigned "background" ROI adjacent to the lower lateral aspect of the LV ROI is used to subtract noncardiac radioactive counts ( fig. 1 ). This selection is automatically performed by the computer without computer-operator interaction. The final (backgroundcorrected) LV time-activity curve, reflecting changes in chamber volume, is then plotted on a hard copy with the absolute counts at end-diastole (early peak of curve) and end-systole (nadir of curve). During transfer of the scintillation data to the computer system, a fixed time frame is set and the total number of cycles displayed.
In the studies in which equations (3) and (4) were used, the following procedures were used. For calculation of plasma volume, the 1251-HSA was injected just after completion of the study. All subsequent blood samples (at 10 and 20 minutes after injection) and the standard dilution were calculated 48 hours later to eliminate the effects of the 99mTc-HSA. In addition, two "butterfly" intravenous catheters were used rather than one. The second catheter was used to remove 10 ml of blood at the midpoint of each study (before 1251-HSA injection). The 10 ml of blood was placed in a heparinized test tube and spun in a centrifuge. Then, 0.1 ml of plasma was pipetted into a second test tube and diluted with 5 ml of tap water. This test tube was then placed in a small well counter (Picker Spectro-Scaler III A). Each tube was counted for 10 seconds for five consecutive 10-second periods at a photopeak of 115-165 keV. The five results were then averaged.
Phantom Study
A cardiac phantom was constructed to assess these techniques independent of other methods such as biplane angiography and to evaluate the effects of photon distortion in relatively large "chamber" volumes. A plastic tank (Alderson phantom) modeled to resemble the thorax was used, in which a 600-ml plastic bottle was suspended and angled to resemble the tilt of the heart. To simulate background, 3500 ml of tap water mixed with 3.5 mCi of 99mTc pertechnetate was used. As material for the "blood pool," 3.5 mCi was placed in a separate 700-ml container. The model was placed on a thin lucite table top and the scintillation camera detector was placed beneath the table, under the phantom. We introduced 10 ml of the "blood pool" material into the open "heart" and collected data with the scintillation camera for 5 minutes. Serial "volumes" were studied at 10-ml increments up to 150 ml; at 20-ml increments up to 310 ml; and then at volumes of 350, 400 and 450 ml. During each study, 0.1 ml was removed from the "blood pool" and Voi 60, No 3, SEPTEMBER 1979 FIGURE I. A) The left ventricular time-activity curve is generated from a rectangular region of interest (RO!) placed by the operator at end-diastole. By use of an edge detection algorithm that combines both count rate decline and maximum rate of ount rate change, the ventricular ROI is followed throughout the cardiac cycle. Panels B and C show the end-diastolic and end-sYstolic frames. D) The computer-generated background (ROI) is shown to the left of the ventricle and is located in the enddiastolic frame. The time-activity curve is actually a composite of over 200 integrated cardiac cycles, with the beginning of the curve coincident with the peak of the R wave of the simultaneously recorded ECG. Each data point represents the total number of counts in each 0.03-second sampling period. EF = ejection fraction; DV/DT = velocity of ventricular ejection.
counted for 10 seconds in a well counter, as described above.
Counts within the simulated ventricle (bottle) were determined by assigning a ROI that included all of the noncontractile "chamber." Assignment was made by light pen rather than by the automated ROI routine, which we felt was justified because we could not rewrite the automated program to accept data from a nonbeating model.
Since the purpose of this experiment was to assess the nonlinear effects of photon absorption in progressively larger volumes, background correction was similarly made, using a consistent light pen assignment in the immediate periphery of the chamber ROI. The background was a complete "ring" around the chamber. Equation (4) was used to compute (relative) volume and to accommodate the count rate decline over the 6-hour duration of the study.
Patients and Protocols Group 1 consisted of 35 patients (nine women, 26 men), average age 52.5 years (range 31-78 years), who underwent gated equilibrium radionuclide angiography before diagnostic cardiac catheterization. All patients were being evaluated for chest pain. Thirtyone of the 35 patients (89%) had obstructive coronary artery disease (70% stenosis in one or more vessels). Seventeen patients (49%) had one or more areas of asynergy at rest. Of these 17 patients, 13 had at least 558 CIRCULATION one akinetic segment. No patient in the group had valvular regurgitation or a ventricular aneurysm. Twenty-five patients had the radionuclide study performed in the catheterization laboratory 1 hour before contrast angiography. Ten additional patients were studied in the nuclear medicine laboratory no more than 18 hours before catheterization. An average of 10.2 mCi/M2 BSA of 99mTc-HSA (range 15-25 mCi) was injected into a forearm vein. Data were collected for 10 minutes in the LAO projection, as described above. The reliability of this method has recently been assessed in relation to angiographic studies.' 5 16 Only equations (1) and (2) were used to assess this population of patients. The nine women had a mean BSA of 1.6 m2 (range 1.2-2 m2), and the 16 men had a mean BSA of 1.9 m2 (range 1.5-2.4). These patients weighed 45-115 kg. Body habitus in this population varied from thin to obese, though no patient weighed more than 15% over his or her ideal body weight.
Group 2 consisted of 17 patients who were studied prospectively in a similar fashion. There were five women and 12 men, average age 40.7 years (range 22-61 years). Of 10 patients with coronary artery disease, two had asynergy (at least one hypokinetic segment) at rest; three had valvular aortic stenosis, two had aortic stenosis and aortic regurgitation, and two had mitral regurgitation. Eleven patients were studied the day before cardiac catheterization and six were studied 36-48 hours after catheterization. In this group, all patients received 12 mCi/M2 BSA 99mTc-HSA (range 17-29 mCi). Accordingly, we did not attempt to normalize the results to a dose of 10 mCi/M2 BSA. Ten of these patients had plasma volume determinations using 1251-HSA (equation 3), and in all 17, the plasma radioactivity concentration was determined (equation 4). In this population, the five women had a mean BSA of 1.5 m2 (range 1.3-1.9 m2), and the 12 men had a mean BSA of 1.9 m2 (range 1.5-2.4 m2). These patients weighed 40-120 kg. The body habitus in these patients varied from slender to moderately obese, but no patient was more than 10% over his or her ideal body weight.
All contrast angiographic volumes were calculated using conventional biplane techniques2 by a person who was unaware of the results of the radionuclide studies. Premature and postpremature beats were not used in the assessment of ventricular volume.
All patients gave written informed consent to all procedures, which were approved by the Committee on Human Investigations Using Human Subjects and Volunteers of the University of California, San Diego. Results
Angiography Data
In the 35 Group 1 patients, the average enddiastolic volume (EDV) was 130 ± 41 (SD) and the average end-systolic volume (ESV) was 60.8 ± 49 ml. In group 2 patients, the angiographic EDV averaged 133 + 70 ml, and ESV averaged 64 ± 52 ml.
Radionuclide Data
Volume Results in Group 1 (Equation 1)
The radionuclide EDV and ESV were compared with angiographic volumes. The correlation coefficient for all 70 volumes was 0.86; r = 0.82 for EDV and r = 0.84 for ESV. The regression equation was y = 0. 129x + 3.62. Using the regression equation to obtain the equivalent volume, the average error of the estimate was 38 ± 24 ml for EDV and 19 ± 17.4 ml for ESV. Volume Results in Group I (Equation 2 )
The normalized radionuclide EDV and ESV were plotted against angiographic results (fig. 2) . The correlation coefficient for all 70 volumes was 0.90; r = 0.85 for EDV and r = 0.87 for ESV. The regression equation was y = 0.14x + 3.12; the average error of the estimate was 21.1 + 15.7 for EDV and 13.5 + 11 ml for ESV. The mean difference (MD) between contrast and radionuclide EDV was -5.86 ml, with a standard error of the difference (SED) of + 4.36 ml. For ESV, MD was -2.08 ml and SED was +2.77 ml. Table I lists 93  139  +47  32  35  +3  125  168  +43  28  60  +32  147  153  +6  76  71  -5  125  122  -3  48  43   -5   98  100  +2  27  14  -13  81  105  +24  23 fig. 4; table 3 ). The correlation coefficient for all 34 volumes was 0.98; for EDV (n = 17) r = 0.97 and for ESV (n = 17) r = 0.98. The average error of the estimate was 11.5 ± 8.5 ml for EDV and 7.3 ± 7.5 ml for ESV. The regression equation was y = 0.0255x -0.121. The MD between contrast and radionuclide volume was +2.94 ml for EDV and -2.11 ml for ESV. The SEDS were +3.47 and 2.37 ml, respectively. The 95% confidence limits are given in figure 4. Reproducibility (table 4) Ten studies were randomly repeated by the same observer at two different times at least 1 month apart.
The difference in counts/cycle was ±1% (r = 0.99).
Ten studies were randomly performed by two different observers. Interobserver variation was also small, with a counts/cycle difference of +1% (r = 0.99).
Assessment of Duration of Study
Fifteen studies were randomly selected. On separate occasions, 10, 5, and 2 minutes of data, respectively, were evaluated from the same patient study. The data were then processed for counts/cycle and compared.
The maximal variation among the three studies was ±4% for the 15 studies (mean 2.1%) for either the EDV or the ESV (r = 0.98) (table 4) . (3) and involve the calculation ofplasma volume. Only 10 of 17 patients in group 2 were studied (n = 20 volumes). The average error of the estimate is +15.7 mlfor end-diastolic volume (EDV), and ±7 ml for end-systolic volume (ESV), using the appropriate regression equation (see text). For both EDV and ESV, n = 10. The dark lines represent 95% confidence limits.
Phantom Data
Twenty-five separate volumes were studied in the order described above. The correlation coefficient for actual and calculated volume was 0.997, y = 0. 1427x + 1.155. ( fig. 5; table 5 ). The average error of the estimate was 6.5 ± 5.1 ml. In this particular study, the 50 100 150 200 250 300 MI CONTRAST ANGIOGRAPHY VOLUME FIGURE 4. Ventricular volumes developed from biplane contrast ventriculography (in milliliters) and equilibrium radionuclide angiography (in nondimensional units) are compared in all 17 patients in group 2. Radionuclide volumes are calculated using equation (4) , which uses a plasma "radioactivity concentration," as described in the text. The average error of the estimate is ± 11.5 mlfor enddiastolic volume (EDV) and 7.3 mlfor end-systolic volume (ESV), using the appropriate regression equation. For EDV and ESV, n = 17. The dark lines represent 95% confidence limits. effects of count attenuation and radioactive decay were not marked, even though large differences in volumes (10-450 ml) were studied and the duration of the experiment exceeded 6 hours (over a full half-life of 99mTc). Corrections for radioactive decay were systematically made by referring to a mock "blood sample" specimen, obtained at the recording of each new volume increment.
Discussion The angiographic assessment of LV volume has been classically based on assumptions regarding LV size and shape. Both single and biplane contrast ventriculography have undergone intensive mathematical analysis by many investigators who have shown good correlations between actual and calculated volumes using a prolate ellipsoid model.'-4 This type of geometric analysis has been applied to the interpretation of echocardiograms'-8 as well as to first-pass and gated equilibrium studies.9 '2 One difficulty of such a model is the validity of the assumptions about LV geometry during contraction.17 18 Decisions must be made concerning the outline of the papillary muscles, which may affect volume estimates derived from analysis of the LV silhouette, especially at end-systole. Additional concerns have included pathologically induced geometric changes, such as aneurysms and wall motion disturbances, that do not conform to the prolate ellipsoid model. 19 Echocardiography, which relies heavily on assumptions that relate the long and short axes, is particularly susceptible to this problem.20' 21
Electrocardiographically gated radionuclide images suffer from difficulty in visualization of the endocardial surfaces. Furthermore, equilibrium radionuclide studies separate the left and right ventricle only in the LAO projection, where accurate measurements of the long axis are difficult; recent mathematical modifications of long-axis calculation may make this approach more practical.22
Because noninvasive evaluations of LV volume often prove erroneous in chambers that do not conform to a prolate ellipsoid model, we have used radionuclide equilibrium ventriculography to circumvent this geometric difficulty by considering counts within the chamber rather than ventricular shape. The initial approach was based on a simple definition of LAU C) LUJ C3 -j C-, 2m CD FM MEASURED VOLUME FIGURE 5. Known phantom volumes (in milliliters) were compared with radionuclide volumes (in nondimensional units) developed using a modification ofequation (4) . A light pen computer program was used to produce a flat volume curve. Because the model was noncontractile, the first five data points were averaged to produce total counts in the ventricular chamber. Cycles were created by an electrocardiographic simulator. Using this variation, an excellent correlation (r = 0.99) and a small estimate error (±6.5 ml) were noted. Mean -SD 6.5 == 5.1 the concentration of a material in a specific volume. Thus, after complete mixing in the entire blood pool, the injected radiotracer was externally measured by quantitating emitted counts from the left ventricle by means of a portable scintillation camera. By assigning a LV ROI, a ventricular volume curve based on the total number of emitted counts detected from within this volume can be generated. Although more activity is probably coming from the anterior than the more posterior chambers of the heart, a relationship between LV counts and actual cardiac volume may be predictable. Our data using normalization for BSA (equation 2) suggest that this is not only feasible but also that it correlates quite well with constant ventriculography. We recognize the inherent problems of this approach, some of which may be explained by the inaccuracy of using BSA as an equivalent for plasma volume. 23 In addition, extravasation of tracer around the intravenous site as well as variations in 99mTc-HSA binding tend to lower the reliability of both equations (1) and (2). Finally, both the biological and radionuclide half-life would prevent use of this technique over a prolonged period. Therefore, we devised equations (3) and (4) to compensate for these errors. In equation (3), the "dose" was normalized by estimating plasma volume using 1251-HSA, which facilitates comparison among patients with large variations in plasma volumes. However, the volume of distribution of iodinated albumin may be different from technetium-labeled albumin, and any volume intervention would be expected to alter the results. Moreover, using iodine-derived concentration excludes the effects. of changing blood pool activity due to radioactive decay and pharmaceutical deterioration.
The approach embodied by equation (4), which provided the best correlation and the smallest error of the estimate, is quite easy to perform, presumably may be used over longer periods of time and is unaffected by alterations in plasma volume. As indicated by the phantom model, there appears to be no influence of radiopharmaceutical deterioration or physical decay in assessing volume. The empiric proof of the method, however, lies in the excellent correlation between angiographic volumes and those derived by the new method.
In summary, we have described a new method for the nontraumatic estimation of LV volume that is safe, simple to perform, accurate and does not require any assumption about ventricular geometry, as with classic ventriculographic methods.
